Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice. 2022

Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
Department of Immunology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.

IL-28B, belonging to type III interferons (IFN-λs), exhibits a potent antitumor activity with reduced regulated T cells (Tregs) population, yet the effect of IL-28B on the tumor microenvironment (TME) and if IL-28B can downregulate Tregs directly in vitro are still unknown. In this study, we investigated the effects of IL-28B on Tregs in the spleen and TME in H22 tumor-bearing mice and verified the downregulation of IL-28B on Tregs in vitro. We found that rAd-mIL-28B significantly inhibited tumor growth and reduced the frequency of splenic CD4+Foxp3+ T cells. The levels of CXCL13, ICAM-1, MCP-5, and IL-7 in the serum, and the levels of IL-15 and sFasL in the tumor tissue decreased significantly after rAd-mIL-28B treatment relative to rAd-EGFP. Furthermore, the percentage of CD8+ cells in the TME was significantly increased in the rAd-mIL-28B group compared with the untreated group. In vitro, splenocytes were stimulated with anti-CD3/CD28 and IL-2 in the presence of TGF-β with or without IL-28B for three days and followed by flow cytometric, RT-PCR, and IL-10 production analysis. The results showed that IL-28B significantly reduced the proportion of induced Foxp3+ cells. It demonstrated that IL-28B may be used as a promising immunotherapy strategy against cancer.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051858 Forkhead Transcription Factors A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila. Forkhead Box Protein,Forkhead Box Transcription Factor,Forkhead Protein,Forkhead Transcription Factor,Forkhead Box Proteins,Forkhead Box Transcription Factors,Forkhead Proteins,Fox Transcription Factors,Box Protein, Forkhead,Box Proteins, Forkhead,Factor, Forkhead Transcription,Protein, Forkhead,Protein, Forkhead Box,Proteins, Forkhead Box,Transcription Factor, Forkhead,Transcription Factors, Forkhead,Transcription Factors, Fox
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
December 2023, JCI insight,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
January 2017, Pharmacognosy magazine,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
June 2018, MedChemComm,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
January 2018, Frontiers in pharmacology,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
June 2023, International immunopharmacology,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
November 2013, International journal of biological macromolecules,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
February 2024, Cancers,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
October 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
September 2005, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine,
Zhi Li, and Jianghua Wang, and Chong Chen, and Qi He, and Xiaoying Xu, and Zejiao Da, and Bo Wang, and Meng Wang, and Xiaotong Gao, and Guochao Zhang, and Qi Gao, and Xiaoli Si, and Yanping Luo, and Xingming Ma
April 2015, Acta pharmacologica Sinica,
Copied contents to your clipboard!